IGC Pharma (FRA:IGS1) Change In Inventory : €1.04 Mil (TTM As of Dec. 2024)

View and export this data going back to 2010. Start your Free Trial

What is IGC Pharma Change In Inventory?

IGC Pharma's change in inventory for the quarter that ended in Dec. 2024 was €0.07 Mil. It means IGC Pharma's inventory declined by €0.07 Mil from Sep. 2024 to Dec. 2024 .

IGC Pharma's change in inventory for the fiscal year that ended in Mar. 2024 was €0.93 Mil. It means IGC Pharma's inventory declined by €0.93 Mil from Mar. 2023 to Mar. 2024 .

IGC Pharma's Total Inventories for the quarter that ended in Dec. 2024 was €1.37 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. IGC Pharma's Days Inventory for the quarter that ended in Dec. 2024 was 853.13.

Inventory Turnover measures how fast the company turns over its inventory within a year. IGC Pharma's Inventory Turnover for the quarter that ended in Dec. 2024 was 0.11.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. IGC Pharma's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 5.57.

IGC Pharma Change In Inventory Historical Data

The historical data trend for IGC Pharma's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IGC Pharma Change In Inventory Chart

IGC Pharma Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Change In Inventory

Get a 7-Day Free Trial

-3.62

-1.04

1.75

0.84

0.93

IGC Pharma Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Change In Inventory	Get a 7-Day Free Trial															-0.02	0.94	0.03	-	0.07

IGC Pharma Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.04 Mil.

IGC Pharma (FRA:IGS1) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

IGC Pharma's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	1.365	/	0.146	*	365 / 4
	=	853.13

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

IGC Pharma's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.146	/	1.365
	=	0.11

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

IGC Pharma's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	1.365	/	0.245
	=	5.57

IGC Pharma Change In Inventory Related Terms

Thank you for viewing the detailed overview of IGC Pharma's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

IGC Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IGC Pharma Inc (FRA:IGS1) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

IGC:USA

Address

10224 Falls Road, Potomac, MD, USA, 20854

Website

https://www.igcinc.us

IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.

IGC Pharma Headlines

No Headlines